MRA (Tocilizumab)

DRUG2 trials

Sponsors

Chugai Pharmaceutical

Conditions

Rheumatoid Arthritis

Phase 3

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP

CompletedNCT00144534

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2004-06-30End: 2009-06-30Updated: 2009-12-23

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

CompletedNCT00144508

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2003-03-31End: 2006-02-28Updated: 2009-02-02